Navigation Links
MCG receives second-time designation from National Cancer Institute
Date:12/20/2007

The Medical College of Georgia has again been designated by the National Cancer Institute as a Minority-Based Community Clinical Oncology Program.

The renewal, which comes with a five-year $2.3 million grant, provides more access to the latest cancer treatment and prevention strategies for all cancer patients, particularly minorities, says Dr. Anand Jillella, chief of the MCG section of Hematology/Oncology and principal investigator on the grant.

The real advantage of the grant is that it is minority-based, which is really relevant here because we have such a significant number of minority patients, says Dr. Kapil N. Bhalla, director of the Medical College of Georgia Cancer Center. The National Cancer Institute recognizes the need to extend studies and clinical trials to those populations and this grant enables us to help advance that initiative by supporting the work done by cancer researchers and clinicians here. This type of work is integral to the overall mission of the Cancer Center - to facilitate and inspire cancer research. It is the perfect marriage of our clinical and research components.

MCG, eligible because more than 40 percent of its newly-diagnosed patients and 40 percent of patients enrolled in clinical trials are minorities, first received the designation in 2004.

The Veterans Affairs Medical Center in Augusta, Aiken Regional Medical Center in Aiken, S.C., and Athens Regional Medical Center in Athens, Ga., are collaborators on the grant.

Dr. Daron G. Ferris, family medicine physician and director of the Gynecologic Cancer Prevention Center at MCG, and Dr. Roger A. Vega, chief of the MCG Section of Pediatric Hematology/Oncology are co-principal investigators.

This designation allows us to continue to broaden the scope of clinical trials and prevention programs by providing support for the infrastructure those initiatives require, Dr. Jillella says.

Unlike the typical grant, program funding supports the infrastructure for dozens of clinical studies instead of just one, says Dr. Jillella.

Before this grant, providing trials was difficult because we could not support the personnel needed for that, he says. Because of the CCOP, we can hire the personnel we need, including research nurses, study coordinators and administrative assistants who are all an important part of clinical research activity.

The grant also allows for collaborative work between adult, preventive and pediatric cancer researchers and clinicians.

One particular way that we have and will continue to benefit from this grant is in the increasing collaboration between adult and pediatric oncology, says Dr. Vega. Having this grant as the common denominator allows us to share. There is a lot that both sides can learn from each other.

For example, he says, young adults who are diagnosed with cancer often fall in the middle between adult and pediatric oncology. While pediatricians treat patients until age 21, many pediatric trials do not apply to those older patients.

Because of the CCOP cooperation, we can extend adult trials to our pediatric patients that wouldnt have been available before, he says.

The grant also provides money for studies on preventing cancer and studies that can help improve the quality of life for patients already undergoing treatments.

Theres a lot of research being done on potential treatments, but theres only a drop in the bucket of studies that focus on the patient with cancer, says Dr. Ferris. When people have cancer, clearly, one of the major goals is to cure it. But we also realize that during that process, some bad things can happen. Thats where we come in. We need to find ways to minimize suffering and make the treatment period more tolerable for the patient. Are there better medications" Alternative treatments for side effects of drugs"

These types of studies also help patients take an active part in their cancer, which gives them hope for themselves, their friends and their families.


'/>"/>

Contact: Jennifer Hilliard
jhilliard@mcg.edu
706-721-8604
Medical College of Georgia  
Source:Eurekalert

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MCG receives second-time designation from National Cancer Institute
(Date:6/28/2017)... ... June 28, 2017 , ... ... been recognized for excellence in employee engagement. Omaha-based C&A Industries, a national ... 50 Most Engaged Workplaces™ in North America for 2017. The annual ...
(Date:6/28/2017)... ... 2017 , ... Hayes, Inc., a leading provider of unbiased ... lineup* for its second annual Client Symposium. Joining the symposium this year are: ... of Privia Health; and Lisa Tourville of Anthem. , “We are thrilled ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... a one-day corporate governance program for mid-market executives as a kick-off to the ... held Sunday, Sept. 24, 2017 on the University of Pennsylvania campus, followed by ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... management and financial planning assistance to clients in southern Montana, is announcing a ... by Zoo Montana. , The outreach programs offered by Zoo Montana provide students ...
(Date:6/27/2017)... ... 2017 , ... Excel Medical, the leader in Next-Generation Medical ... Executive Vice President, Sales and Marketing. Finnegan is a widely known industry leader ... leadership. He has received industry recognition for innovations and new approaches to sales ...
Breaking Medicine News(10 mins):
(Date:6/20/2017)... and LAGUNA HILLS, Calif. , June ... new data that validate the use of MMprofiler with ... with multiple myeloma (MM). In a poster presentation at ... Association (EHA) in Madrid, Spain , ... for identifying high-risk elderly patients. In ...
(Date:6/14/2017)... 14, 2017  ivWatch LLC, a medical device company ... (IV) therapy, is pleased to announce it was the ... Hospital Supplies and Equipment at the 2017 Medical Design ... medtech industry. The award was presented by Medical Device ... Center in New York during ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: